PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity.
J Immunother Cancer
; 11(10)2023 10.
Article
in En
| MEDLINE
| ID: mdl-37793852
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Precursor Cell Lymphoblastic Leukemia-Lymphoma
/
Programmed Cell Death 1 Receptor
Limits:
Animals
/
Humans
Language:
En
Journal:
J Immunother Cancer
Year:
2023
Type:
Article
Affiliation country:
United States